Aim: To evaluate whether high-intensity interval training (HIIT) with a lower time commitment can be as effective as endurance training (END) on glycaemic control, physical fitness and body composition in individuals with type 2 diabetes. Results: Exercise training increased VO 2 peak more in the HIIT group (20% AE 20%) compared with the END group (8% AE 9%) despite lower total energy expenditure and time usage during the training sessions. HIIT decreased whole body and android fat mass compared with the CON group. In addition, visceral fat mass, HbA1c, fasting glucose, postprandial glucose, glycaemic variability and HOMA-IR decreased after HIIT. The reduced postprandial glucose in the HIIT group was driven primarily by a lower rate of exogenous glucose appearance. In the CON group, postprandial lipolysis was augmented over the 11-week control period.
given that "lack of time" is one of the most cited barriers to participation in regular physical activity. 14, 15 The aim of the present study was to evaluate the effect of 11 weeks of low-volume HIIT compared to traditional moderateintensity endurance training (END) on glycaemic control, with HbA1c as the primary outcome, and on physical fitness and body composition as secondary outcomes in individuals with T2D. We hypothesized that, despite the lower training-derived energy expenditure, low-volume HIIT would be as effective as END in improving glycaemic control, physical fitness and body composition.
| MATERIALS AND METHODS

| Participants
After initial screening of 193 individuals with T2D, we enrolled 29 in the study. A standardized medical examination including blood chemistry analysis, a resting 12-lead electrocardiogram and an oral glucose tolerance test (OGTT) were performed before inclusion.
Participants were excluded if they were treated with exogenous insulin; were smokers; had unstable weight (change >5 kg/6 months); had illness that contraindicated physical training; or demonstrated evidence of renal, liver or cardiovascular disease. All participants were under adequate treatment at baseline and none changed medication during the study. The study (ClinicalTrials.gov ID no: NCT02001766) was approved by the Ethics Committee of the Capital Region of Denmark (H-2-2011-070) and signed informed consent was obtained from all participants before enrolment.
An incremental cycling test using a bicycle ergometer (839E; Monark, Varberg, Sweden) was performed to determine VO 2 peak (Cosmed Quark b 2 , Rome, Italy), peak workload (W peak ) and peak heart rate (HR peak ). The test consisted of a 5-minute warm-up, followed by 1-minute periods of increasing workload until 2 of the following criteria were met: plateauing of VO 2 with incremental workloads, respiratory exchange ratio >1.1, cycling cadence <60 rpm or volitional exhaustion. The VO 2 peak test was repeated after 4 and 8 weeks of training to ensure that the relative workload was maintained throughout the training period.
| Experimental design
A parallel 3-group, prospective design was applied. After baseline tests, participants were given opaque sealed envelopes randomly allocating them to 3 groups: control (CON) (initially n = 8), END (initially n = 10) and HIIT (initially n = 11). Two participants dropped out of the study for personal reasons unrelated to the experiment (one from the CON group and one from the HIIT group) and one participant from the HIIT group was excluded because of unstable diabetes treatment. Participants in the CON group were offered rerandomization to 1 of the training groups after the intervention period; 6 accepted re-allocation. The final study population after dropout and including reallocation consisted of 26 participants (CON, n = 7; END, n = 12; HIIT, n = 13) ( Figure S1 ).
| Exercise intervention
Participants in the training groups entered an 11-week bicycle inter- 
| Calculations
Glucose and glycerol tracer analyses were performed using liquid chromatography mass spectrometry by a hexobenzoyl derivatization method. 19 Glucose and glycerol kinetics were determined using nonsteady-state assumptions as previously described. 20 Total rate of glu- Glucose, insulin, C-peptide and glycerol responses were calculated using the standard trapezoidal method as area under the curve (AUC) change from baseline during OGTT (apart from glycerol) and the meal test. 21 The initial first phase insulin and C-peptide responses during
OGTT and the meal test were determined as the incremental response during the first 10 minutes, calculated as delta of T = 0 and T = 10 (Δ0-10 minutes). 22 Insulin resistance was assessed applying Bonferroni post hoc tests were used to examine the difference between means in the event of a significant finding. Training variables were compared using the unpaired, 2-tailed Student t-test.
Statistical significance was accepted when P was less than .05. All data are presented as mean AE SD. For technical reasons and/or because of catheter displacement all tracer samples could not be obtained either pre-or post-intervention in 7 participants (CON, n = 2; END, n = 1; HIIT, n = 4).
3 | RESULTS
| Participant characteristics
Participant characteristics and intervention-induced changes in variables of interest are presented in Table 1 . Energy intake did not change in any of the groups (Table 2 ). However, energy intake was lower in the CON group compared to the END group after the intervention (P < .05).
| Exercise
Training compliance did not differ between the END and the HIIT groups ( Table 2 ). Estimated energy expenditure during training sessions was 36% higher in the END group, when compared to the HIIT group (P < .05). VO 2 peak and W peak increased in both the END and the HIIT groups (P < .05) and the increase in VO 2 peak was higher (20% AE 20%) in the HIIT group compared to the END group (8% AE 9%: P < .05).
| Body composition
HIIT lowered whole body mass (P < .05) (Figure 2A ), the overall amount of android fat (P < .05) ( Figure 2B ) and the amount of visceral fat mass (P < .05) ( Figure 2D ). No changes in whole body mass, android fat or visceral fat mass were found in the CON or END groups. However, the END group showed a reduction in gynoid fat mass (P < .05) ( Figure 2C ) and a tendency to reduction in whole body mass (P = .08) and visceral fat mass (P = .06).
| Glycaemic control
No changes in any OGTT variables were observed among the 3 groups (Table 1) , but fasting glucose, HbA1c levels and glycaemic variability were reduced in the HIIT group (P < .05), whereas the END group showed a significant decrease in mean CGM glucose concentration and in time in hyperglycemic range (P < .05).
3.5 | Glucose and glycerol kinetics during exercise and meal tests 3.
| Plasma glucose
Basal plasma glucose values did not differ within or between groups after the intervention ( Figure S2A ). In the HIIT group there was a time × trial interaction (P < .05) and post hoc analyses showed that in the HIIT group, plasma glucose during exercise (T = 30-55; P < .05) and during the meal test (T = 150-240; P < .05) was lower after the training period. Plasma glucose during exercise was also lowered in the CON group at 1 time point only (T = 55; P < .05). In addition, maximum plasma glucose values during meals were lower in the HIIT group (P < .05), while it was unaltered in both the CON and END groups. Plasma glucose AUC decreased only in the HIIT group (P < .05).
No group differences in R aTotal , R d , R aEND or R aMeal were found.
During exercise, R aTotal and R d were lower in the END group after the intervention (T = 55; both P < .05) ( Figure S2B ,C), whereas R aEND was lower in all groups (CON, T = 55; END, T = 55; HIIT, T = 30, all P < .05) ( Figure S2D ) during exercise. In the HIIT group, AUC R aTotal decreased (P < .05) and R d during the meal was lower after the intervention (T = 180-240; P < .05) in the HIIT group, while R aTotal and R d during the meal were unaltered in both the CON and END groups.
R aEND was lower during the meal, at T = 70 to 120 (P < .05) in the CON group, at T = 120 (P < .05) in the END group and at T = 80 to 90 in the HIIT group (both P < .05). In addition, R aEND AUC during the meal decreased in the END group (P < .05) after the intervention, and tended to decrease in the CON group (P = .052). Postprandial suppression of R aEND tended to be larger in the HIIT group after the intervention (P = .06), and the change was greater when compared to the END group (P < .05). R aMeal AUC decreased in the HIIT group (P < .05) ( Figure S2E ) after the intervention, while it was unaltered in both the CON and END groups.
| Rate of glucose clearance
In the END and HIIT groups there was a time x trial interaction (P < .05) and glucose clearance during exercise was lower in the END group (T = 55) and during the meal in the HIIT group (T = 80) after the intervention, while no difference was found in the CON group.
| Plasma glycerol
Plasma glycerol values did not differ within or between groups after the intervention ( Figure S3 ), but tended to be higher in the CON group at baseline (P = .07) and during exercise after the intervention (T = 30; P = .06).
No differences among groups in R aTotal , R d , absolute R aEND or R aEND at baseline or during exercise were found, but AUC R aTotal and AUC R d were higher in the CON group, as compared to the END group (both P < .05) and AUC R aTotal tended to be higher than in the HIIT group (P = .051) ( Figure S4 ), while AUC R d was higher (P < .05).
Also, AUC absolute R aEND and AUC R aEND were higher in the CON group (P < .05), and this change was different as compared to the END and HIIT groups (all P < .05). In the END and HIIT groups, R aTotal, Rd , absolute R aEND and R aEND during exercise were lower after the intervention (END, T = 30-55; all P < .05; HIIT, T = 30; P < .05). 
| Insulin and C-peptide
Fasting (OGTT) ( Table 1) , basal (Meal) ( Figure S5 ) plasma insulin and C-peptide levels and insulin during exercise did not differ within or between groups after the intervention. Within groups, C-peptide was lower during exercise in the END group (T = 30-55; both P < .05) and during meals in the HIIT group (T = 210-240, P < .05) after the intervention, whereas C-peptide AUC increased in the CON group. In addition, maximum C-peptide values during the meal were lower in the HIIT group and higher in the CON group after the intervention (both P < .05). Furthermore, HIIT lowered HOMA-IR (P < .05) ( Table 1 ). First phase insulin and C-peptide responses during OGTT and the meal did not differ in any group. In addition, no change in the Matsuda index or in the hepatic insulin resistance index was found.
| DISCUSSION
The main finding of the study was that 11 weeks of low-volume high-intensity interval training (HIIT) in individuals with T2D induced Training intensity (% peak heart rate) refers to fraction of average training heart rate as compared with the peak heart rate measured during VO 2 peak tests. Data are presented as mean AE SD. * indicates P < 0.05, a time × group interaction (2-way ANOVA), b Δ CON vs END (1-way ANOVA), c END vs HIIT (unpaired, 2-tailed Student t-test). similar or greater improvements in glycaemic control, body composition and physical fitness to moderate-intensity endurance training (END). Postprandial plasma glucose during the mixed meal test was lower in the HIIT group after the training period, despite a decrease in C-peptide concentration.
To investigate whether HIIT can be recommended as a timeefficient alternative to traditional endurance training for patients with T2D, we designed our protocol so that the training volume was 45% lower in the HIIT group. Despite this difference in training volume, the HIIT and END groups displayed comparable effects on the peak workload and VO 2 peak increased more in the HIIT group than in the END group (20% vs 8%). There were no injuries, hypoglycaemic events or drop-out related to HIIT, and overall compliance in the HIIT group (91%) was similar to that in the END group (94%). Collectively, these observations suggest that HIIT is a safe exercise modality, with greater effects on aerobic fitness compared with END.
We observed a reduction in HbA1c and fasting glucose in the HIIT group, indicating that endogenous glucose production was affected in the group performing HIIT. The lower endogenous glucose appearance induced by HIIT was predominantly of hepatic origin. Lower endogenous glucose production after exercise training in T2D patients has been demonstrated previously by Kirwan et al., 26 who found that 7 days of vigorous exercise training enhanced the suppression of hepatic glucose production as a result of improved hepatic insulin sensitivity. This finding is in agreement with the improvement in HOMA-IR in the HIIT group in the present study.
Although we found no change in either the Matsuda index, the hepatic insulin resistance index or in the insulin response to OGTT or the meal test, postprandial C-peptide was lower during the meal after HIIT, indicating that hepatic insulin sensitivity indeed was affected by HIIT. C-peptide is a better indicator of insulin secretion than insulin itself 27 and, in healthy individuals, glucose-stimulated insulin secretion is normally lowered after a training period, as the result of improved insulin sensitivity. 28, 29 In contrast to the HIIT group, we observed an increased postprandial C-peptide response in the CON group, indicating that the amount of insulin needed to maintain a normal glucose level was increased, that is, an impaired insulin sensitivity. The reduced rate of endogenous glucose appearance in the CON group may have occurred, in part, in the face of the observed increase in C-peptide response, which may have attenuated hepatic glucose production. However, paradoxically, this lower hepatic glucose production had no impact on postprandial plasma glucose. Moreover, the postprandial rate of glycerol appearance, a direct index of lipolysis, was increased in the CON group despite the higher C-peptide response.
Thus, in the CON group, postprandial adipose tissue insulin sensitivity seemed to be reduced, whereas exercise training prevented this deteriorating effect in both the END and HIIT groups.
The reduced postprandial amount of total glucose appearing in the HIIT group after training was primarily driven by a reduced amount of exogenous glucose entering the circulation. Although our study did not allow us to control for differences in gastric emptying rates, in the glucose concentration gradient between the gut and the circulation or in hepatic glucose uptake, these finding support the idea that hepatic sensitivity was improved in the HIIT group. Moreover, the slow release of ingested glucose to the circulation probably explains the decreased C-peptide response in the HIIT group. 36 and OGTT responses may not reflect day-today glycaemic control, 37 given that it, unlike the meal test and CGM, does not represent a meal that participants encounter in real life.
Weight loss induced by exercise training is predominantly thought to be the result of increased energy expenditure during the actual exercise performed. 38 However, we found a significant reduction in whole body mass and the amount of android and visceral fat only in the HIIT group, despite the~36% higher energy expenditure during training in the END group and a similar energy intake between training groups.
This finding could be related to both an increased energy expenditure in the recovery phase of HIIT 39 and higher plasma catecholamine levels during HIIT, driving lipolysis post exercise. 40, 41 The fact that the visceral fat mass was lowered in the HIIT group could be of clinical importance, as accumulation of visceral fat has been associated with increased risk of T2D and cardiovascular disease. 42 In the present study, the END group trained 135 min/wk, which is less than the recommended 150 min/wk of moderate-to-vigorous exercise training, whereas the HIT group performed the minimum recommended time of vigorous intensity exercise (75 min/wk). 14 Exercise training for more than 150 min/wk has been linked to greater improvements in HbA1c (0.89%) compared to training less than 150 min/wk (0.36%), 6 and the overall stimulus may therefore have been suboptimal in the END group. Importantly, the change in HbA1c in the HIIT group was 2.1% despite the short duration of weekly training.
A limitation of the present study is the relatively small number of participants, which may have masked differences between HIIT and END. T2D is heterogeneous and between-group differences in baseline characteristics, albeit not significant, may potentially have prevented the finding of statistical differences during the intervention period. Moreover, it is important to recognize that precise determination of energy expenditure during non-steady state training is difficult.
In summary, we have demonstrated that low-volume HIIT can improve glycaemic control, aerobic fitness and body composition in individuals with T2D. HIIT results in similar or even greater adaptations when compared to moderate-intensity training, despite a lower training volume. Given that lack of time is the most cited barrier to regular exercise, low-volume HIIT appears to be clinically important as a timeefficient strategy to improve glycaemic control in individuals with T2D.
